Deutsche EuroShop (DEQ) Stock Chart & Stock Price History → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free DEQ Stock Alerts €19.00 +0.08 (+0.42%) (As of 04/18/2024 ET) Add Compare Share Share ChartStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Deutsche EuroShop Stock Price Performance5 Day Performance+0.42%1 Month Performance0.00%3 Month Performance-0.94%6 Month Performance-4.52%Year-To-Date Performance-15.74%1 Year Performance-0.52% Receive DEQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Deutsche EuroShop and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> DEQ Stock Chart for Friday, April, 19, 2024 DEQ Chart by TradingView Deutsche EuroShop Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2024€18.68€18.92+1.28%€19.00€18.5011,504 shs$1.45 billion04/17/2024€18.86€18.68-0.95%€18.86€18.6210,151 shs$1.43 billion04/16/2024€18.92€18.86-0.32%€19.00€18.846,726 shs$1.44 billion04/15/2024€18.92€18.92€18.96€18.7612,665 shs$1.45 billion04/12/2024€18.82€18.92+0.53%€18.98€18.749,261 shs$1.45 billion04/11/2024€18.96€18.82-0.74%€19.04€18.7610,261 shs$1.44 billion Get the Latest News and Ratings for DEQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Deutsche EuroShop and its competitors with MarketBeat's FREE daily newsletter. 04/10/2024€19.00€18.96-0.21%€19.00€18.929,536 shs$1.45 billion04/09/2024€18.96€19.00+0.21%€19.00€18.9210,518 shs$1.45 billion04/08/2024€18.96€18.96€19.00€18.907,652 shs$1.45 billion04/05/2024€18.86€18.96+0.53%€19.00€18.907,652 shs$1.45 billion04/04/2024€18.90€18.86-0.21%€19.00€18.808,087 shs$1.44 billion04/03/2024€18.90€18.90€19.46€18.9010,934 shs$1.45 billion04/02/2024€18.98€18.90-0.42%€19.46€18.9010,934 shs$1.45 billion04/01/2024€18.98€18.98€19.02€18.9811,582 shs$1.45 billion03/29/2024€18.98€18.98€19.02€18.9811,582 shs$1.45 billion03/28/2024€19.04€18.98-0.32%€19.02€18.9811,582 shs$1.45 billion03/27/2024€19.04€19.04€19.04€18.9016,570 shs$1.46 billion03/26/2024€18.92€19.04+0.63%€19.04€18.7025,492 shs$1.46 billion03/25/2024€18.92€18.92€19.00€18.769,781 shs$1.45 billion03/22/2024€19.00€18.70-1.58%€18.82€18.569,226 shs$1.43 billion03/21/2024€19.00€19.00€19.08€18.8819,140 shs$1.45 billion03/20/2024€19.00€19.00€19.00€18.9217,919 shs$1.45 billion03/19/2024€18.36€19.00+3.49%€19.08€18.6023,383 shs$1.45 billion03/18/2024€18.36€18.36€18.68€18.2233,031 shs$1.40 billion03/15/2024€18.90€18.56-1.80%€18.98€18.5617,112 shs$1.42 billion03/14/2024€18.84€18.90+0.32%€18.98€18.7016,881 shs$1.45 billion03/13/2024€18.76€18.84+0.43%€18.86€18.747,409 shs$1.44 billion03/12/2024€18.84€18.76-0.42%€18.90€18.726,651 shs$1.43 billion03/11/2024€18.84€18.84€19.00€18.7212,322 shs$1.44 billion03/08/2024€18.92€18.86-0.32%€19.02€18.6212,658 shs$1.44 billion03/07/2024€18.80€18.92+0.64%€19.16€18.7832,801 shs$1.45 billion03/06/2024€18.74€18.80+0.32%€19.00€18.704,937 shs$1.44 billion03/05/2024€18.74€18.74€19.02€18.6812,660 shs$1.43 billion03/04/2024€18.78€18.74-0.21%€19.02€18.6812,660 shs$1.43 billion03/01/2024€18.86€18.76-0.53%€19.04€18.7414,025 shs$1.43 billion02/29/2024€18.90€18.86-0.21%€18.94€18.7810,569 shs$1.44 billion02/28/2024€18.80€18.90+0.53%€19.12€18.9037,362 shs$1.45 billion02/27/2024€18.80€18.80€19.00€18.747,795 shs$1.44 billion02/26/2024€18.98€18.80-0.95%€19.00€18.747,795 shs$1.44 billion02/23/2024€18.96€18.94-0.11%€19.04€18.8413,105 shs$1.45 billionTiny Biotech Stock Wins $75 Billion Patent (Ad)A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>>02/22/2024€18.72€18.96+1.28%€19.00€18.709,859 shs$1.45 billion02/21/2024€18.70€18.72+0.11%€18.88€18.6411,446 shs$1.43 billion02/20/2024€18.60€18.70+0.54%€19.00€18.667,089 shs$1.43 billion02/19/2024€18.60€18.60€18.80€18.509,574 shs$1.42 billion02/16/2024€18.54€18.68+0.76%€18.92€18.509,720 shs$1.43 billion02/15/2024€18.54€18.54€18.84€18.549,057 shs$1.42 billion02/14/2024€19.06€18.54-2.73%€18.84€18.549,057 shs$1.42 billion02/13/2024€18.70€19.06+1.93%€19.22€18.5010,031 shs$1.46 billion02/12/2024€18.70€18.70€19.24€18.7010,951 shs$1.43 billion02/09/2024€18.92€18.92€19.26€18.9217,580 shs$1.45 billion02/08/2024€19.04€18.92-0.63%€19.26€18.9217,580 shs$1.45 billion02/07/2024€18.98€19.04+0.32%€19.12€18.9214,079 shs$1.46 billion02/06/2024€18.72€18.98+1.39%€19.26€18.8214,784 shs$1.45 billion02/05/2024€18.72€18.72€19.56€18.7237,487 shs$1.43 billion02/02/2024€19.94€18.72-6.12%€19.56€18.7237,487 shs$1.43 billion02/01/2024€19.94€19.94€20.05€19.889,886 shs$1.52 billion01/31/2024€20.00€19.94-0.30%€20.05€19.889,886 shs$1.52 billion01/30/2024€20.00€20.00€20.20€19.987,155 shs$1.53 billion01/29/2024€19.90€20.00+0.50%€20.20€19.987,155 shs$1.53 billion01/26/2024€20.30€20.30€20.30€19.888,179 shs$1.55 billion01/25/2024€19.60€20.30+3.57%€20.30€19.888,179 shs$1.55 billion01/24/2024€19.60€19.60€19.70€19.3615,491 shs$1.50 billion01/23/2024€19.50€19.60+0.51%€19.70€19.3615,491 shs$1.50 billion01/22/2024€19.50€19.50€19.50€19.103,699 shs$1.49 billion01/19/2024€19.18€19.18€19.52€19.048,025 shs$1.47 billion01/18/2024€19.40€19.18-1.13%€19.52€19.048,025 shs$1.47 billion Related Companies: Adler Real Estate Stock Chart Aroundtown Stock Chart TAG Immobilien Stock Chart Scout24 Stock Chart alstria office REIT Stock Chart WCM Beteiligungs- und Grundbesitz Stock Chart DIC Asset Stock Chart Adler Group Stock Chart CORESTATE Capital Stock Chart Deutsche Wohnen Stock Chart Receive DEQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Deutsche EuroShop and its competitors with MarketBeat's FREE daily newsletter. This page (ETR:DEQ) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Deutsche EuroShop AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.